4//SEC Filing
Frapaise Francois-Xavier 4
Accession 0001142576-10-000025
CIK 0001142576other
Filed
May 16, 8:00 PM ET
Accepted
May 17, 7:12 PM ET
Size
5.0 KB
Accession
0001142576-10-000025
Insider Transaction Report
Form 4
Frapaise Francois-Xavier
SVP, Chief Scientific Officer
Transactions
- Other
Common stock
2010-05-17$9.57/sh+1,494$14,299→ 2,906 total
Footnotes (1)
- [F1]Acquired under the Company's employee stock purchase plan on May 17, 2010.
Documents
Issuer
OPTIMER PHARMACEUTICALS INC
CIK 0001142576
Entity typeother
Related Parties
1- filerCIK 0001455044
Filing Metadata
- Form type
- 4
- Filed
- May 16, 8:00 PM ET
- Accepted
- May 17, 7:12 PM ET
- Size
- 5.0 KB